Pravastatin Sodium Tablet
Product Images NDC 16714-570

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 16714-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label-10mg (Container Label 10mg)

The label is for Pravastatin Sodium Tablets, USP, 10 mg strength, in a bottle of 90 tablets. It includes storage instructions, manufacturing details (Northstar Rx LLC and Glenmark Pharmaceuticals Limited), and a barcode. The label emphasizes the drug is for prescription use only and provides information on keeping the product tightly closed and protected from light and moisture.*

FDA Label Image

Container Label-20mg (Container Label 20mg)

Label for Pravastatin Sodium Tablets USP, 20 mg strength, oral tablets. The carton contains 90 tablets and is manufactured for NorthStar Rx LLC, Memphis, TN, and by Glenmark Pharmaceuticals Limited, Goa, India. The label includes storage instructions and a barcode.*

FDA Label Image

Container Label-40mg (Container Label 40mg)

Label for Pravastatin Sodium Tablets, USP 40 mg, oral tablet form. The package contains 90 tablets. It is manufactured for NorthStar Rx LLC, Memphis, TN, and manufactured by Glenmark Pharmaceuticals Limited, Goa, India. The label includes storage instructions and a barcode.*

FDA Label Image

Container Label-80mg (Container Label 80mg)

Pravastatin Sodium 80 mg Tablets, USP label for oral use. The carton indicates 90 tablets per package. Manufactured by Glenmark Pharmaceuticals Limited in India for NorthStar Rx LLC. Storage instructions specify controlled room temperature and protection from moisture and light. The label includes an NDC and barcode.*

FDA Label Image

Img-1 (F6ff3db8 5a51 406f 9070 369855b3469a 01)

A survival distribution plot showing the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over approximately 5 years. The graph compares two groups: Placebo and Pravastatin, with the Pravastatin group having a lower survival proportion over time. The x-axis represents years since randomization, and the y-axis represents the proportion of subjects without the event.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of pravastatin sodium, showing its molecular formula C23H35NaO7 and molecular weight 446.52. The diagram illustrates the arrangement of atoms and bonds in this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.